{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:23:01Z","timestamp":1790342581847,"version":"4.1.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ccm.2023.08.004","type":"journal-article","created":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T15:14:23Z","timestamp":1698506063000},"page":"71-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Cutaneous Sarcoidosis"],"prefix":"10.1016","volume":"45","author":[{"given":"Mariam","family":"Abdelghaffar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Damsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ccm.2023.08.004_bib1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0733-8635(02)00010-4","article-title":"Sarcoidosis","volume":"20","author":"Giuffrida","year":"2002","journal-title":"Dermatol Clin"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.004_bib2","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ccm.2015.08.010","article-title":"Cutaneous sarcoidosis","volume":"36","author":"Wanat","year":"2015","journal-title":"Clin Chest Med"},{"issue":"12","key":"10.1016\/j.ccm.2023.08.004_bib3","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1164\/rccm.200402-249OC","article-title":"A\u00a0case control etiologic study of sarcoidosis","volume":"170","author":"Newman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2023.08.004_bib4","doi-asserted-by":"crossref","unstructured":"Judson MA, Thompson BW, Rabin DL, et\u00a0al. The diagnostic pathway to sarcoidosis\u2217. Chest. 2003;123(2):406-412.","DOI":"10.1378\/chest.123.2.406"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.004_bib5","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12955-020-01542-6","article-title":"Factors affecting health-related quality of life in patients with skin disease: cross-sectional results from 8,789 patients with 16 skin diseases","volume":"18","author":"He","year":"2020","journal-title":"Health Qual Life Outcomes"},{"issue":"12","key":"10.1016\/j.ccm.2023.08.004_bib6","doi-asserted-by":"crossref","first-page":"e0244765","DOI":"10.1371\/journal.pone.0244765","article-title":"Psychosocial impact of skin diseases: a population-based study","volume":"15","author":"Yew","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.004_bib7","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2340\/00015555-1920","article-title":"Quality of life and emotional state in chronic skin disease","volume":"95","author":"P\u00e4rna","year":"2015","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.004_bib8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ad.2016.11.008","article-title":"The impact of skin diseases on quality of life: a multicenter study","volume":"108","author":"Sanclemente","year":"2017","journal-title":"Actas Dermosifiliogr"},{"issue":"6","key":"10.1016\/j.ccm.2023.08.004_bib9","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jaad.2013.06.053","article-title":"Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors","volume":"69","author":"Miller","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.ccm.2023.08.004_bib10","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/archderm.1997.03890430098013","article-title":"Cutaneous involvement in sarcoidosis","volume":"133","author":"Ma\u00f1\u00e1","year":"1997","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.004_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4103\/CDR.CDR_39_19","article-title":"Scar sarcoidosis: a dermatologic masquerader","volume":"5","author":"Rani","year":"2021","journal-title":"Clinical Dermatology Review"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.004_bib12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0095-4543(21)00273-6","article-title":"Cutaneous lesions of sarcoidosis","volume":"5","author":"Elgart","year":"1978","journal-title":"Prim Care"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.004_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0738-081X(86)90032-5","article-title":"Cutaneous sarcoidosis: definitions and types of lesions","volume":"4","author":"Elgart","year":"1986","journal-title":"Clin Dermatol"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.004_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/ijd.12248","article-title":"Cutaneous sarcoidosis: clinicopathologic study of 76 patients from Lebanon","volume":"54","author":"Ishak","year":"2015","journal-title":"Int J Dermatol"},{"issue":"10","key":"10.1016\/j.ccm.2023.08.004_bib15","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1001\/archinte.1985.00360100071011","article-title":"Cutaneous manifestations of sarcoidosis. Relationships to other organ system involvement, abnormal laboratory measurements, and disease course","volume":"145","author":"Olive","year":"1985","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.004_bib16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0190-9622(90)70061-L","article-title":"Sarcoidosis of the upper respiratory tract in patients with nasal rim lesions: a pilot study","volume":"22","author":"Jorizzo","year":"1990","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.004_bib17","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1378\/chest.08-1347","article-title":"The treatment of lupus pernio","volume":"135","author":"Stagaki","year":"2009","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.004_bib18","first-page":"86","article-title":"Sarcoidosis on tattoos: a review of the literature from 1939 to 2011","volume":"30","author":"Kluger","year":"2013","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.004_bib19","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1001\/archderm.1939.01490020083011","article-title":"Reactions in tattoos","volume":"40","author":"MADDEN","year":"1939","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.004_bib20","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1503\/cmaj.110696","article-title":"Tattoo reactions as a sign of sarcoidosis: figure 1","volume":"184","author":"Post","year":"2012","journal-title":"Can Med Assoc J"},{"issue":"9","key":"10.1016\/j.ccm.2023.08.004_bib21","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1346-8138.2010.00900.x","article-title":"Lupus pernio with multiple bone cysts in the fingers","volume":"37","author":"NAGAI","year":"2010","journal-title":"J\u00a0Dermatol"},{"issue":"8","key":"10.1016\/j.ccm.2023.08.004_bib22","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1001\/archderm.1984.01650440058020","article-title":"Subcutaneous sarcoidosis","volume":"120","author":"Vainsencher","year":"1984","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.004_bib23","doi-asserted-by":"crossref","first-page":"T147","DOI":"10.1016\/j.ad.2022.03.027","article-title":"[Translated article] dactylitis due to subcutaneous sarcoidosis as a manifestation of sarcoidosis","volume":"114","author":"Marcoval","year":"2023","journal-title":"Actas Dermosifiliogr"},{"issue":"5","key":"10.1016\/j.ccm.2023.08.004_bib24","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-2230.1995.tb01367.x","article-title":"Subcutaneous sarcoidosis with dactylitis","volume":"20","author":"CURCO","year":"1995","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"10.1016\/j.ccm.2023.08.004_bib25","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/ard.42.6.634","article-title":"Sarcoid dactylitis","volume":"42","author":"Pitt","year":"1983","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.004_bib26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/0378-6323.30645","article-title":"Cutaneous sarcoidosis: clinical profile of 23 Indian patients","volume":"73","author":"Sharma","year":"2007","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.004_bib27","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.amjmed.2009.08.014","article-title":"Recurrent telangiectasias on the cheek: angiolupoid sarcoidosis","volume":"123","author":"Arias Santiago","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.ccm.2023.08.004_bib28","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jdcr.2020.11.016","article-title":"Treatment of angiolupoid sarcoidosis with tofacitinib ointment 2% and pulsed dye laser therapy","volume":"7","author":"Singh","year":"2021","journal-title":"JAAD Case Rep"},{"issue":"11","key":"10.1016\/j.ccm.2023.08.004_bib29","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1046\/j.1365-4362.1999.00839.x","article-title":"Cutaneous sarcoidosis in black South Africans","volume":"38","author":"Jacyk","year":"1999","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.ccm.2023.08.004_bib30","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3892\/etm.2021.10803","article-title":"Cutaneous sarcoidosis of the scalp unmasking systemic involvement: a case report","volume":"22","author":"Boda","year":"2021","journal-title":"Exp Ther Med"},{"issue":"6","key":"10.1016\/j.ccm.2023.08.004_bib31","first-page":"344","article-title":"Sarcoidosis: nail dystrophy without underlying bone changes","volume":"55","author":"Wakelin","year":"1995","journal-title":"Cutis"},{"issue":"6","key":"10.1016\/j.ccm.2023.08.004_bib32","doi-asserted-by":"crossref","first-page":"627","DOI":"10.4103\/jisp.jisp_378_16","article-title":"Oral manifestation of sarcoidosis: a case report and review of the literature","volume":"20","author":"Radochova","year":"2016","journal-title":"J\u00a0Indian Soc Periodontol"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.004_bib33","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1186\/s13256-021-03044-5","article-title":"Melkersson\u2013Rosenthal syndrome in the context of sarcoidosis: a case report","volume":"15","author":"Casper","year":"2021","journal-title":"J\u00a0Med Case Rep"},{"issue":"10","key":"10.1016\/j.ccm.2023.08.004_bib34","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"BAUGHMAN","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.004_bib35","first-page":"217","article-title":"Digital clubbing in sarcoidosis","volume":"34","author":"Shah","year":"1992","journal-title":"Indian J Chest Dis Allied Sci"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.004_bib36","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/archderm.1983.01650280005004","article-title":"Nails in sarcoidosis: response to treatment","volume":"119","author":"Patel","year":"1983","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.004_bib37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11882-021-00991-3","article-title":"Distinguishing blau syndrome from systemic sarcoidosis","volume":"21","author":"Kaufman","year":"2021","journal-title":"Curr Allergy Asthma Rep"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.004_bib38","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1525-1470.1987.tb00796.x","article-title":"Sarcoidosis in children","volume":"4","author":"Clark","year":"1987","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.004_bib39","first-page":"57","article-title":"Childhood sarcoidosis","volume":"5","author":"James","year":"1988","journal-title":"Sarcoidosis"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.004_bib40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/2049-6958-8-26","article-title":"Diagnosis of cutaneous sarcoidosis; clinical and the prognostic significance of skin lesions","volume":"8","author":"Yanardag","year":"2013","journal-title":"Multidiscip Respir Med"},{"issue":"6","key":"10.1016\/j.ccm.2023.08.004_bib41","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1468-3083.2009.03153.x","article-title":"Cutaneous sarcoidosis: a histopathological study","volume":"23","author":"Cardoso","year":"2009","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"12","key":"10.1016\/j.ccm.2023.08.004_bib42","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1600-0560.2006.00563.x","article-title":"Clinical spectrum and histological analysis of 32 cases of specific cutaneous sarcoidosis","volume":"33","author":"Mangas","year":"2006","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.ccm.2023.08.004_bib43","series-title":"Sarcoidosis","article-title":"Propionibacterium acnes as a cause of sarcoidosis","author":"Eishi","year":"2013"},{"key":"10.1016\/j.ccm.2023.08.004_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/935289","article-title":"Etiologic aspect of sarcoidosis as an allergic endogenous infection caused by Propionibacterium acnes","volume":"2013","author":"Eishi","year":"2013","journal-title":"BioMed Res Int"},{"issue":"10","key":"10.1016\/j.ccm.2023.08.004_bib45","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/thx.2007.094060","article-title":"Heredity in sarcoidosis: a registry-based twin study","volume":"63","author":"Sverrild","year":"2008","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.004_bib46","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1183\/09031936.00033812","article-title":"Genome-wide association analysis reveals 12q13.3\u2013q14.1 as new risk locus for sarcoidosis","volume":"41","author":"Hofmann","year":"2013","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.004_bib47","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1183\/09031936.00159912","article-title":"Genetic predisposition to sarcoidosis: another brick in the wall: Table\u00a01","volume":"41","author":"Spagnolo","year":"2013","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.004_bib48","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1053\/j.gastro.2008.07.017","article-title":"Genome-wide association analysis in sarcoidosis and crohn\u2019s disease unravels a common susceptibility locus on 10p12.2","volume":"135","author":"Franke","year":"2008","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.004_bib49","first-page":"201","article-title":"Effects of broad-spectrum antimycobacterial therapy on chronic pulmonary sarcoidosis","volume":"30","author":"Drake","year":"2013","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"10","key":"10.1016\/j.ccm.2023.08.004_bib50","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210785","article-title":"CD4+ T cells in the lungs of acute sarcoidosis patients recognize an Aspergillus nidulans epitope","volume":"218","author":"Greaves","year":"2021","journal-title":"J\u00a0Exp Med"},{"issue":"8","key":"10.1016\/j.ccm.2023.08.004_bib51","first-page":"2633","article-title":"Current insights in genetics of sarcoidosis: functional and clinical impacts","volume":"9","author":"Calender","year":"2020","journal-title":"J\u00a0Clin Med"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.004_bib52","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1183\/09031936.00035213","article-title":"Major histocompatibility complex class II and BTNL2 associations in sarcoidosis: Table\u00a01","volume":"42","author":"Wennerstr\u00f6m","year":"2013","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.004_bib53","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng1519","article-title":"Sarcoidosis is associated with a truncating splice site mutation in BTNL2","volume":"37","author":"Valentonyte","year":"2005","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.004_bib54","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/thx.2005.056564","article-title":"BTNL2 gene variant and sarcoidosis","volume":"61","author":"Li","year":"2006","journal-title":"Thorax"},{"issue":"9","key":"10.1016\/j.ccm.2023.08.004_bib55","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/BF03402194","article-title":"Accumulation of common clonal T cells in multiple lesions of sarcoidosis","volume":"6","author":"Sawabe","year":"2000","journal-title":"Molecular Medicine"},{"issue":"9","key":"10.1016\/j.ccm.2023.08.004_bib56","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/1756-185X.13076","article-title":"Immunotherapy-induced sarcoidosis in patients with melanoma treated with PD-1 checkpoint inhibitors: case series and immunophenotypic analysis","volume":"20","author":"Lomax","year":"2017","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.004_bib57","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1159\/000484596","article-title":"Pulmonary sarcoidosis activation following neoadjuvant pembrolizumab plus chemotherapy combination therapy in a patient with non-small cell lung cancer: a case report","volume":"10","author":"Fakhri","year":"2017","journal-title":"Case Rep Oncol"},{"issue":"11","key":"10.1016\/j.ccm.2023.08.004_bib58","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra2101555","article-title":"Challenges of sarcoidosis and its management","volume":"385","author":"Drent","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.004_bib59","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.humimm.2017.10.009","article-title":"Evidence for M2 macrophages in granulomas from pulmonary sarcoidosis: a new aspect of macrophage heterogeneity","volume":"79","author":"Shamaei","year":"2018","journal-title":"Hum Immunol"},{"issue":"6","key":"10.1016\/j.ccm.2023.08.004_bib60","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jaad.2011.06.017","article-title":"Molecular profiling and gene expression analysis in cutaneous sarcoidosis: the role of interleukin-12, interleukin-23, and the T-helper 17 pathway","volume":"66","author":"Judson","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"26","key":"10.1016\/j.ccm.2023.08.004_bib61","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1056\/NEJMoa1805958","article-title":"Tofacitinib treatment and molecular analysis of cutaneous sarcoidosis","volume":"379","author":"Damsky","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.004_bib62","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1038\/s41598-017-04109-6","article-title":"Identification of Jak-STAT signaling involvement in sarcoidosis severity via a novel microRNA-regulated peripheral blood mononuclear cell gene signature","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.004_bib63","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/09273941003797934","article-title":"The expression of STAT-1 and phosphorylated STAT-1 in conjunctival granulomas","volume":"18","author":"Rosenbaum","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"issue":"9","key":"10.1016\/j.ccm.2023.08.004_bib64","doi-asserted-by":"crossref","first-page":"e44818","DOI":"10.1371\/journal.pone.0044818","article-title":"Peripheral blood gene expression as a novel genomic biomarker in complicated sarcoidosis","volume":"7","author":"Zhou","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.004_bib65","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.clim.2009.04.010","article-title":"Hypothesis: sarcoidosis is a STAT1-mediated disease","volume":"132","author":"Rosenbaum","year":"2009","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.004_bib66","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.immuni.2023.01.014","article-title":"Single-cell and spatial transcriptomics reveal aberrant lymphoid developmental programs driving granuloma formation","volume":"56","author":"Krausgruber","year":"2023","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.ccm.2023.08.004_bib67","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.004_bib68","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1046\/j.1365-2133.2002.04727.x","article-title":"Cutaneous sarcoidosis successfully treated with topical tacrolimus","volume":"147","author":"Katoh","year":"2002","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.004_bib69","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-2230.2007.02397.x","article-title":"Topical tacrolimus for the treatment of cutaneous sarcoidosis","volume":"32","author":"Green","year":"2007","journal-title":"Clin Exp Dermatol"},{"issue":"12","key":"10.1016\/j.ccm.2023.08.004_bib70","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1111\/jdv.12606","article-title":"Disfiguring papular sarcoidosis of the face: dramatic improvement with pimecrolimus","volume":"29","author":"La Placa","year":"2015","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ccm.2023.08.004_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdcr.2020.12.021","article-title":"Treatment of cutaneous sarcoidosis with tofacitinib 2% ointment and extra virgin olive oil","volume":"9","author":"Alam","year":"2021","journal-title":"JAAD Case Rep"},{"issue":"7","key":"10.1016\/j.ccm.2023.08.004_bib72","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/archderm.1991.01680060108015","article-title":"Treatment of cutaneous sarcoidosis with chloroquine. Review of the literature","volume":"127","author":"Zic","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ccm.2023.08.004_bib73","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010817.pub2","article-title":"Interventions for cutaneous sarcoidosis","author":"Jadotte","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.004_bib74","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000155647","article-title":"Photodynamic therapy as an alternative treatment for cutaneous sarcoidosis","volume":"217","author":"Wilsmann-Theis","year":"2008","journal-title":"Dermatology"},{"issue":"5","key":"10.1016\/j.ccm.2023.08.004_bib75","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2340\/00015555-2864","article-title":"Light and laser modalities in the treatment of cutaneous sarcoidosis: a systematic review","volume":"98","author":"Lima","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ccm.2023.08.004_bib76","doi-asserted-by":"crossref","first-page":"102870","DOI":"10.1016\/j.pdpdt.2022.102870","article-title":"Photodynamic therapy for the local control of refractory cutaneous sarcoidosis of the head: case report and review of the literature","volume":"39","author":"Gracia-Darder","year":"2022","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"6","key":"10.1016\/j.ccm.2023.08.004_bib77","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/jamadermatol.2013.2977","article-title":"Oral minocycline in treatment of cutaneous sarcoidosis","volume":"149","author":"Steen","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.004_bib78","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.137.1.69","article-title":"The use of tetracyclines for the treatment of sarcoidosis","volume":"137","author":"Bachelez","year":"2001","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.004_bib79","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0190-9622(90)70246-E","article-title":"Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas","volume":"23","author":"Jones","year":"1990","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.004_bib80","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40257-014-0079-3","article-title":"A\u00a0practical approach to cutaneous sarcoidosis","volume":"15","author":"Wanat","year":"2014","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.004_bib81","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1378\/chest.14-0015","article-title":"A\u00a0randomized, investigator-masked, double-blind, placebo-controlled trial on thalidomide in severe cutaneous sarcoidosis","volume":"146","author":"Droitcourt","year":"2014","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.ccm.2023.08.004_bib82","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","article-title":"Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement","volume":"174","author":"Baughman","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.ccm.2023.08.004_bib83","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1183\/09031936.00051907","article-title":"Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial","volume":"31","author":"Judson","year":"2008","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.ccm.2023.08.004_bib84","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jaad.2012.10.056","article-title":"A\u00a0double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis","volume":"68","author":"Pariser","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.ccm.2023.08.004_bib85","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jamadermatol.2017.1162","article-title":"Efficacy and tolerance of anti\u2013tumor necrosis factor \u03b1 agents in cutaneous sarcoidosis","volume":"153","author":"Heidelberger","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.ccm.2023.08.004_bib86","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jaad.2020.12.010","article-title":"Paradoxical eruptions to targeted therapies in dermatology: a systematic review and analysis","volume":"86","author":"Murphy","year":"2022","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.004_bib87","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1038\/s41467-022-30615-x","article-title":"Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis","volume":"13","author":"Damsky","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ccm.2023.08.004_bib88","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jdcr.2021.08.012","article-title":"Treatment of cutaneous sarcoidosis with tofacitinib: a case report and review of evidence for Janus kinase inhibition in sarcoidosis","volume":"16","author":"Talty","year":"2021","journal-title":"JAAD Case Rep"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.004_bib89","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/08998280.2013.11929014","article-title":"The heerfordt-waldenstr\u00f6m syndrome as an initial presentation of sarcoidosis","volume":"26","author":"Denny","year":"2013","journal-title":"Baylor University Medical Center Proceedings"},{"issue":"1138","key":"10.1016\/j.ccm.2023.08.004_bib90","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1136\/postgradmedj-2019-137219","article-title":"Sarcoidosis with multiorgan involvement","volume":"96","author":"Morasert","year":"2020","journal-title":"Postgrad Med J"},{"issue":"5","key":"10.1016\/j.ccm.2023.08.004_bib91","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/00000372-198910000-00005","article-title":"Miescher\u02bcs radial granuloma A characteristic marker of erythema nodosum","volume":"11","author":"S\u00e1nchez Yus","year":"1989","journal-title":"Am J Dermatopathol"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.004_bib92","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2340\/00015555726971","article-title":"Successful treatment of chronic skin diseases with clobetasol propionate and a hydrocolloid occlusive dressing","volume":"72","author":"Volden","year":"1992","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"10.1016\/j.ccm.2023.08.004_bib93","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archderm.1995.01690170121026","article-title":"Lupus pernio: successful treatment with a potent topical corticosteroid","volume":"131","author":"Khatri","year":"1995","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.ccm.2023.08.004_bib94","first-page":"659","article-title":"Verrucous cutaneous sarcoidosis in an adolescent with dark skin","volume":"20","author":"Corradin","year":"2010","journal-title":"Eur J Dermatol"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.004_bib95","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1001\/jama.1953.03690040012005","article-title":"Local injection of hydrocortisone and cortisone into skin lesions of sarcoidosis","volume":"152","author":"Sullivan","year":"1953","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.004_bib96","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3341\/kjo.2006.20.4.238","article-title":"A\u00a0case of scar sarcoidosis of the eyelid","volume":"20","author":"Kim","year":"2006","journal-title":"Kor J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.004_bib97","first-page":"89","article-title":"Lichenoid type of cutaneous sarcoidosis: great response to topical tacrolimus","volume":"18","author":"Vano-Galvan","year":"2008","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.ccm.2023.08.004_bib98","first-page":"1","article-title":"Topical pimecrolimus as a new optional treatment in cutaneous sarcoidosis of lichenoid type","volume":"2014","author":"Tammaro","year":"2014","journal-title":"Case Rep Dermatol Med"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.004_bib99","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/archderm.1997.03890380087013","article-title":"Ulcerative sarcoidosis. Case report and review of the literature","volume":"133","author":"Albertini","year":"1997","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.004_bib100","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1365-2133.2005.06815.x","article-title":"Subcutaneous sarcoidosis-clinicopathological study of 10 cases","volume":"153","author":"Marcoval","year":"2005","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.004_bib101","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.clindermatol.2007.03.011","article-title":"Evidence-based therapy for cutaneous sarcoidosis","volume":"25","author":"Baughman","year":"2007","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.ccm.2023.08.004_bib102","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.rmed.2015.11.007","article-title":"A\u00a0retrospective pilot study examining the use of Acthar gel in sarcoidosis patients","volume":"110","author":"Baughman","year":"2016","journal-title":"Respir Med"},{"issue":"6","key":"10.1016\/j.ccm.2023.08.004_bib103","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/ced.14614","article-title":"Clinical phenotypes and therapeutic responses in cutaneous-predominant sarcoidosis: 6-year experience in a tertiary referral service","volume":"46","author":"Paolino","year":"2021","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.004_bib104","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2133.1977.tb15068.x","article-title":"Cutaneous sarcoidosis treated with methotrexate","volume":"97","author":"VEIEN","year":"1977","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.ccm.2023.08.004_bib105","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1001\/archinte.1995.00430080088011","article-title":"Prolonged use of methotrexate for sarcoidosis","volume":"155","author":"Lower","year":"1995","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.004_bib106","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-2133.2003.05042.x","article-title":"Mycophenolate mofetil may serve as a steroid-sparing agent for sarcoidosis","volume":"148","author":"Kouba","year":"2003","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.004_bib107","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.biopha.2012.03.005","article-title":"Thalidomide for improving cutaneous and pulmonary sarcoidosis in patients resistant or with contraindications to corticosteroids","volume":"66","author":"Fazzi","year":"2012","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.004_bib108","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jaad.2003.07.006","article-title":"Treatment of cutaneous sarcoidosis with thalidomide","volume":"50","author":"Nguyen","year":"2004","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.004_bib109","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1378\/chest.122.1.227","article-title":"Thalidomide for chronic sarcoidosis","volume":"122","author":"Baughman","year":"2002","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.004_bib110","first-page":"289","article-title":"Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trial","volume":"32","author":"Baughman","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.004_bib111","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jaad.2011.05.040","article-title":"Infliximab as a steroid-sparing agent in refractory cutaneous sarcoidosis: single-center retrospective study of 9 patients","volume":"66","author":"Sen\u00e9","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.004_bib112","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1378\/chest.127.3.1064","article-title":"Treatment of sarcoidosis with infliximab","volume":"127","author":"Doty","year":"2005","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ccm.2023.08.004_bib113","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1183\/09031936.00000914","article-title":"Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis","volume":"44","author":"Judson","year":"2014","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.ccm.2023.08.004_bib114","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archdermatol.2012.1322","article-title":"Case series demonstrating improvement in chronic cutaneous sarcoidosis following treatment with TNF inhibitors","volume":"148","author":"Wanat","year":"2012","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.004_bib115","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jaad.2020.10.016","article-title":"Tofacitinib for cutaneous and pulmonary sarcoidosis: a case series","volume":"84","author":"Kerkemeyer","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.ccm.2023.08.004_bib116","doi-asserted-by":"crossref","unstructured":"Damsky W, Wang A, Young B, et\u00a0al. Treatment of Sarcoidosis with Cutaneous Involvement with Tofacitinib. Published online 2021.","DOI":"10.1101\/2021.07.01.21259700"},{"issue":"7","key":"10.1016\/j.ccm.2023.08.004_bib117","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1524-4725.2009.01202.x","article-title":"Successful treatment of cutaneous sarcoidosis lesions with the flashlamp pumped pulsed dye laser","volume":"35","author":"ROOS","year":"2009","journal-title":"Dermatol Surg"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.004_bib118","first-page":"393","article-title":"Scar sarcoidosis in a child: case report of successful treatment with the pulsed dye laser","volume":"34","author":"HOLZMANN","year":"2008","journal-title":"Dermatol Surg"},{"issue":"5","key":"10.1016\/j.ccm.2023.08.004_bib119","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/lsm.1900120515","article-title":"Treatment of lupus pernio with the flashlamp pulsed dye laser","volume":"12","author":"Goodman","year":"1992","journal-title":"Lasers Surg Med"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523123000734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523123000734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:17:11Z","timestamp":1759454231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523123000734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":119,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0272523123000734"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2023.08.004","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous Sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2023.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}